Selected research
Market Outlook & Growth Opportunities
Global Physician Advisory Services Market Outlook and Growth Opportunities 2026
Market perspective
The global Physician Advisory Services market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.
The North America market for Physician Advisory Services is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The Europe market for Physician Advisory Services is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Physician Advisory Services is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
In China, the Physician Advisory Services market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Major global companies in the Physician Advisory Services market include R1 RCM, Remedi Health Solutions, Physician Advisory Solutions, MedsRole, Sound Physician, Xsolis, AppriseMD, DCCS Consulting and CorroHealth, Inc, among others. In 2025, the top three vendors together accounted for approximately % of global market revenue.
This report provides an overview of the global Physician Advisory Services market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Physician Advisory Services and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Physician Advisory Services revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global Physician Advisory Services market.
Physician Advisory Services Segment by Company
R1 RCM
Remedi Health Solutions
Physician Advisory Solutions
MedsRole
Sound Physician
Xsolis
AppriseMD
DCCS Consulting
CorroHealth, Inc
Precision Healthcare Consultant
Med-Metrix
EdiPhy Advisors
Optum
Physician Advisory Services Segment by Type
On-Site
Remote
Physician Advisory Services Segment by Application
Healthcare Payers
Healthcare Providers
Others
Physician Advisory Services Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global Physician Advisory Services status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.
2. To present the Physician Advisory Services key companies, revenue, market share, and recent developments.
3. To split the Physician Advisory Services breakdown data by regions, type, companies, and application.
4. To analyze the global and key regions Physician Advisory Services market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify Physician Advisory Services significant trends, drivers, influence factors in global and regions.
6. To analyze Physician Advisory Services competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Physician Advisory Services market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Physician Advisory Services and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Physician Advisory Services.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size.
Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Physician Advisory Services industry.
Chapter 3: Detailed analysis of Physician Advisory Services company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales value of Physician Advisory Services in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.
Chapter 7: Sales value of Physician Advisory Services in country level. It provides sigmate data by type, and by application for each country/region.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 9: Concluding Insights.
More report detail
Tables and figures
List of Tables
Table 1. Physician Advisory Services Industry Trends
Table 2. Physician Advisory Services Industry Drivers
Table 3. Physician Advisory Services Industry Opportunities and Challenges
Table 4. Physician Advisory Services Industry Restraints
Table 5. Global Physician Advisory Services Revenue by Company (US$ Million) & (2021-2026)
Table 6. Global Physician Advisory Services Revenue Share by Company (2021-2026)
Table 7. Global Physician Advisory Services Company Ranking, (2024-2026) & (US$ Million)
Table 8. Global Physician Advisory Services Key Company Manufacturing Base & Headquarters
Table 9. Global Physician Advisory Services Company, Product Type & Application
Table 10. Global Physician Advisory Services Company Establishment Date
Table 11. Global Company Market Concentration Ratio (CR5 and HHI)
Table 12. Global Physician Advisory Services by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025)
Table 13. Mergers & Acquisitions, Expansion
Table 14. Significant Companies of On-Site
Table 15. Significant Companies of Remote
Table 16. Global Physician Advisory Services Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million)
Table 17. Global Physician Advisory Services Sales Value by Type (2021-2026) & (US$ Million)
Table 18. Global Physician Advisory Services Sales Value by Type (2027-2032) & (US$ Million)
Table 19. Global Physician Advisory Services Sales Value Share by Type (2021-2026)
Table 20. Global Physician Advisory Services Sales Value Share by Type (2027-2032)
Table 21. Significant Companies of Healthcare Payers
Table 22. Significant Companies of Healthcare Providers
Table 23. Significant Companies of Others
Table 24. Global Physician Advisory Services Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million)
Table 25. Global Physician Advisory Services Sales Value by Application (2021-2026) & (US$ Million)
Table 26. Global Physician Advisory Services Sales Value by Application (2027-2032) & (US$ Million)
Table 27. Global Physician Advisory Services Sales Value Share by Application (2021-2026)
Table 28. Global Physician Advisory Services Sales Value Share by Application (2027-2032)
Table 29. Global Physician Advisory Services Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million)
Table 30. Global Physician Advisory Services Sales Value by Region (2021-2026) & (US$ Million)
Table 31. Global Physician Advisory Services Sales Value Share by Region (2021-2026)
Table 32. Global Physician Advisory Services Sales Value by Region (2027-2032) & (US$ Million)
Table 33. Global Physician Advisory Services Sales Value Share by Region (2027-2032)
Table 34. Global Physician Advisory Services Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million)
Table 35. Global Physician Advisory Services Sales Value by Country (2021-2026) & (US$ Million)
Table 36. Global Physician Advisory Services Sales Value Market Share by Country (2021-2026)
Table 37. Global Physician Advisory Services Sales Value by Country (2027-2032) & (US$ Million)
Table 38. Global Physician Advisory Services Sales Value Market Share by Country (2027-2032)
Table 39. R1 RCM Company Information
Table 40. R1 RCM Business Overview
Table 41. R1 RCM Physician Advisory Services Revenue (US$ Million) and Gross Margin (2021-2026)
Table 42. R1 RCM Physician Advisory Services Product Portfolio
Table 43. R1 RCM Recent Development
Table 44. Remedi Health Solutions Company Information
Table 45. Remedi Health Solutions Business Overview
Table 46. Remedi Health Solutions Physician Advisory Services Revenue (US$ Million) and Gross Margin (2021-2026)
Table 47. Remedi Health Solutions Physician Advisory Services Product Portfolio
Table 48. Remedi Health Solutions Recent Development
Table 49. Physician Advisory Solutions Company Information
Table 50. Physician Advisory Solutions Business Overview
Table 51. Physician Advisory Solutions Physician Advisory Services Revenue (US$ Million) and Gross Margin (2021-2026)
Table 52. Physician Advisory Solutions Physician Advisory Services Product Portfolio
Table 53. Physician Advisory Solutions Recent Development
Table 54. MedsRole Company Information
Table 55. MedsRole Business Overview
Table 56. MedsRole Physician Advisory Services Revenue (US$ Million) and Gross Margin (2021-2026)
Table 57. MedsRole Physician Advisory Services Product Portfolio
Table 58. MedsRole Recent Development
Table 59. Sound Physician Company Information
Table 60. Sound Physician Business Overview
Table 61. Sound Physician Physician Advisory Services Revenue (US$ Million) and Gross Margin (2021-2026)
Table 62. Sound Physician Physician Advisory Services Product Portfolio
Table 63. Sound Physician Recent Development
Table 64. Xsolis Company Information
Table 65. Xsolis Business Overview
Table 66. Xsolis Physician Advisory Services Revenue (US$ Million) and Gross Margin (2021-2026)
Table 67. Xsolis Physician Advisory Services Product Portfolio
Table 68. Xsolis Recent Development
Table 69. AppriseMD Company Information
Table 70. AppriseMD Business Overview
Table 71. AppriseMD Physician Advisory Services Revenue (US$ Million) and Gross Margin (2021-2026)
Table 72. AppriseMD Physician Advisory Services Product Portfolio
Table 73. AppriseMD Recent Development
Table 74. DCCS Consulting Company Information
Table 75. DCCS Consulting Business Overview
Table 76. DCCS Consulting Physician Advisory Services Revenue (US$ Million) and Gross Margin (2021-2026)
Table 77. DCCS Consulting Physician Advisory Services Product Portfolio
Table 78. DCCS Consulting Recent Development
Table 79. CorroHealth, Inc Company Information
Table 80. CorroHealth, Inc Business Overview
Table 81. CorroHealth, Inc Physician Advisory Services Revenue (US$ Million) and Gross Margin (2021-2026)
Table 82. CorroHealth, Inc Physician Advisory Services Product Portfolio
Table 83. CorroHealth, Inc Recent Development
Table 84. Precision Healthcare Consultant Company Information
Table 85. Precision Healthcare Consultant Business Overview
Table 86. Precision Healthcare Consultant Physician Advisory Services Revenue (US$ Million) and Gross Margin (2021-2026)
Table 87. Precision Healthcare Consultant Physician Advisory Services Product Portfolio
Table 88. Precision Healthcare Consultant Recent Development
Table 89. Med-Metrix Company Information
Table 90. Med-Metrix Business Overview
Table 91. Med-Metrix Physician Advisory Services Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026)
Table 92. Med-Metrix Physician Advisory Services Product Portfolio
Table 93. Med-Metrix Recent Development
Table 94. EdiPhy Advisors Company Information
Table 95. EdiPhy Advisors Business Overview
Table 96. EdiPhy Advisors Physician Advisory Services Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026)
Table 97. EdiPhy Advisors Physician Advisory Services Product Portfolio
Table 98. EdiPhy Advisors Recent Development
Table 99. Optum Company Information
Table 100. Optum Business Overview
Table 101. Optum Physician Advisory Services Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026)
Table 102. Optum Physician Advisory Services Product Portfolio
Table 103. Optum Recent Development
Table 104. Research Programs/Design for This Report
Table 105. Authors List of This Report
Table 106. Secondary Sources
Table 107. Primary Sources
List of Figures
Figure 1. Physician Advisory Services Product Image
Figure 2. Global Physician Advisory Services Market Size (US$ Million), 2021 VS 2025 VS 2032
Figure 3. Global Physician Advisory Services Market Size (2021-2032) & (US$ Million)
Figure 4. Global Physician Advisory Services Company Revenue Ranking in 2025 (US$ Million)
Figure 5. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million)
Figure 6. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025
Figure 7. On-Site Image
Figure 8. Remote Image
Figure 9. Global Physician Advisory Services Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million)
Figure 10. Global Physician Advisory Services Sales Value Share 2021 VS 2025 VS 2032
Figure 11. Global Physician Advisory Services Sales Value Share by Type (2021-2032)
Figure 12. Healthcare Payers Image
Figure 13. Healthcare Providers Image
Figure 14. Others Image
Figure 15. Global Physician Advisory Services Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million)
Figure 16. Global Physician Advisory Services Sales Value Share 2021 VS 2025 VS 2032
Figure 17. Global Physician Advisory Services Sales Value Share by Application (2021-2032)
Figure 18. Global Physician Advisory Services Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million)
Figure 19. Global Physician Advisory Services Sales Value Share by Region: 2021 VS 2025 VS 2032
Figure 20. North America Physician Advisory Services Sales Value (2021-2032) & (US$ Million)
Figure 21. North America Physician Advisory Services Sales Value Share by Country (%), 2025 VS 2032
Figure 22. Europe Physician Advisory Services Sales Value (2021-2032) & (US$ Million)
Figure 23. Europe Physician Advisory Services Sales Value Share by Country (%), 2025 VS 2032
Figure 24. Asia-Pacific Physician Advisory Services Sales Value (2021-2032) & (US$ Million)
Figure 25. Asia-Pacific Physician Advisory Services Sales Value Share by Country (%), 2025 VS 2032
Figure 26. South America Physician Advisory Services Sales Value (2021-2032) & (US$ Million)
Figure 27. South America Physician Advisory Services Sales Value Share by Country (%), 2025 VS 2032
Figure 28. Middle East & Africa Physician Advisory Services Sales Value (2021-2032) & (US$ Million)
Figure 29. Middle East & Africa Physician Advisory Services Sales Value Share by Country (%), 2025 VS 2032
Figure 30. USA Physician Advisory Services Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 31. USA Physician Advisory Services Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 32. USA Physician Advisory Services Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 33. Canada Physician Advisory Services Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 34. Canada Physician Advisory Services Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 35. Canada Physician Advisory Services Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 36. Mexico Physician Advisory Services Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 37. Mexico Physician Advisory Services Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 38. Mexico Physician Advisory Services Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 39. Germany Physician Advisory Services Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 40. Germany Physician Advisory Services Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 41. Germany Physician Advisory Services Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 42. France Physician Advisory Services Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 43. France Physician Advisory Services Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 44. France Physician Advisory Services Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 45. U.K. Physician Advisory Services Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 46. U.K. Physician Advisory Services Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 47. U.K. Physician Advisory Services Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 48. Italy Physician Advisory Services Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 49. Italy Physician Advisory Services Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 50. Italy Physician Advisory Services Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 51. Spain Physician Advisory Services Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 52. Spain Physician Advisory Services Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 53. Spain Physician Advisory Services Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 54. Russia Physician Advisory Services Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 55. Russia Physician Advisory Services Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 56. Russia Physician Advisory Services Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 57. Netherlands Physician Advisory Services Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 58. Netherlands Physician Advisory Services Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 59. Netherlands Physician Advisory Services Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 60. Nordic Countries Physician Advisory Services Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 61. Nordic Countries Physician Advisory Services Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 62. Nordic Countries Physician Advisory Services Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 63. China Physician Advisory Services Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 64. China Physician Advisory Services Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 65. China Physician Advisory Services Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 66. Japan Physician Advisory Services Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 67. Japan Physician Advisory Services Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 68. Japan Physician Advisory Services Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 69. South Korea Physician Advisory Services Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 70. South Korea Physician Advisory Services Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 71. South Korea Physician Advisory Services Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 72. India Physician Advisory Services Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 73. India Physician Advisory Services Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 74. India Physician Advisory Services Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 75. Australia Physician Advisory Services Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 76. Australia Physician Advisory Services Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 77. Australia Physician Advisory Services Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 78. Southeast Asia Physician Advisory Services Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 79. Southeast Asia Physician Advisory Services Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 80. Southeast Asia Physician Advisory Services Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 81. Brazil Physician Advisory Services Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 82. Brazil Physician Advisory Services Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 83. Brazil Physician Advisory Services Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 84. Argentina Physician Advisory Services Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 85. Argentina Physician Advisory Services Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 86. Argentina Physician Advisory Services Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 87. Chile Physician Advisory Services Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 88. Chile Physician Advisory Services Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 89. Chile Physician Advisory Services Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 90. Colombia Physician Advisory Services Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 91. Colombia Physician Advisory Services Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 92. Colombia Physician Advisory Services Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 93. Peru Physician Advisory Services Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 94. Peru Physician Advisory Services Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 95. Peru Physician Advisory Services Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 96. Saudi Arabia Physician Advisory Services Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 97. Saudi Arabia Physician Advisory Services Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 98. Saudi Arabia Physician Advisory Services Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 99. Israel Physician Advisory Services Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 100. Israel Physician Advisory Services Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 101. Israel Physician Advisory Services Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 102. UAE Physician Advisory Services Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 103. UAE Physician Advisory Services Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 104. UAE Physician Advisory Services Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 105. Turkey Physician Advisory Services Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 106. Turkey Physician Advisory Services Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 107. Turkey Physician Advisory Services Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 108. Iran Physician Advisory Services Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 109. Iran Physician Advisory Services Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 110. Iran Physician Advisory Services Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 111. Egypt Physician Advisory Services Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 112. Egypt Physician Advisory Services Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 113. Egypt Physician Advisory Services Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 114. Years Considered
Figure 115. Research Process
Figure 116. Key Executives Interviewed
Scope & coverage.
Types
- On-Site
- Remote
Applications
- Healthcare Payers
- Healthcare Providers
- Others
Companies covered
- R1 RCM
- Remedi Health Solutions
- Physician Advisory Solutions
- MedsRole
- Sound Physician
- Xsolis
- AppriseMD
- DCCS Consulting
- CorroHealth, Inc
- Precision Healthcare Consultant
- Med-Metrix
- EdiPhy Advisors
- Optum
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Physician Advisory Services Market Size, 2021 VS 2025 VS 2032
- 1.3 Global Physician Advisory Services Market Size (2021-2032)
- 1.4 Assumptions and Limitations
- 1.5 Study Goals and Objectives
2 Physician Advisory Services Market Dynamics
- 2.1 Physician Advisory Services Industry Trends
- 2.2 Physician Advisory Services Industry Drivers
- 2.3 Physician Advisory Services Industry Opportunities and Challenges
- 2.4 Physician Advisory Services Industry Restraints
3 Physician Advisory Services Market by Company
- 3.1 Global Physician Advisory Services Company Revenue Ranking in 2025
- 3.2 Global Physician Advisory Services Revenue by Company (2021-2026)
- 3.3 Global Physician Advisory Services Company Ranking (2024-2026)
- 3.4 Global Physician Advisory Services Company Manufacturing Base and Headquarters
- 3.5 Global Physician Advisory Services Company Product Type and Application
- 3.6 Global Physician Advisory Services Company Establishment Date
- 3.7 Market Competitive Analysis
- 3.7.1 Global Physician Advisory Services Market Concentration Ratio (CR5 and HHI)
- 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
- 3.7.3 2025 Physician Advisory Services Tier 1, Tier 2, and Tier 3 Companies
- 3.8 Mergers and Acquisitions Expansion
4 Physician Advisory Services Market by Type
- 4.1 Physician Advisory Services Type Introduction
- 4.1.1 On-Site
- 4.1.2 Remote
- 4.2 Global Physician Advisory Services Sales Value by Type
- 4.2.1 Global Physician Advisory Services Sales Value by Type (2021 VS 2025 VS 2032)
- 4.2.2 Global Physician Advisory Services Sales Value by Type (2021-2032)
- 4.2.3 Global Physician Advisory Services Sales Value Share by Type (2021-2032)
5 Physician Advisory Services Market by Application
- 5.1 Physician Advisory Services Application Introduction
- 5.1.1 Healthcare Payers
- 5.1.2 Healthcare Providers
- 5.1.3 Others
- 5.2 Global Physician Advisory Services Sales Value by Application
- 5.2.1 Global Physician Advisory Services Sales Value by Application (2021 VS 2025 VS 2032)
- 5.2.2 Global Physician Advisory Services Sales Value by Application (2021-2032)
- 5.2.3 Global Physician Advisory Services Sales Value Share by Application (2021-2032)
6 Physician Advisory Services Regional Value Analysis
- 6.1 Global Physician Advisory Services Sales Value by Region: 2021 VS 2025 VS 2032
- 6.2 Global Physician Advisory Services Sales Value by Region (2021-2032)
- 6.2.1 Global Physician Advisory Services Sales Value by Region: 2021-2026
- 6.2.2 Global Physician Advisory Services Sales Value by Region (2027-2032)
- 6.3 North America
- 6.3.1 North America Physician Advisory Services Sales Value (2021-2032)
- 6.3.2 North America Physician Advisory Services Sales Value Share by Country, 2025 VS 2032
- 6.4 Europe
- 6.4.1 Europe Physician Advisory Services Sales Value (2021-2032)
- 6.4.2 Europe Physician Advisory Services Sales Value Share by Country, 2025 VS 2032
- 6.5 Asia-Pacific
- 6.5.1 Asia-Pacific Physician Advisory Services Sales Value (2021-2032)
- 6.5.2 Asia-Pacific Physician Advisory Services Sales Value Share by Country, 2025 VS 2032
- 6.6 South America
- 6.6.1 South America Physician Advisory Services Sales Value (2021-2032)
- 6.6.2 South America Physician Advisory Services Sales Value Share by Country, 2025 VS 2032
- 6.7 Middle East & Africa
- 6.7.1 Middle East & Africa Physician Advisory Services Sales Value (2021-2032)
- 6.7.2 Middle East & Africa Physician Advisory Services Sales Value Share by Country, 2025 VS 2032
7 Physician Advisory Services Country-level Value Analysis
- 7.1 Global Physician Advisory Services Sales Value by Country: 2021 VS 2025 VS 2032
- 7.2 Global Physician Advisory Services Sales Value by Country (2021-2032)
- 7.2.1 Global Physician Advisory Services Sales Value by Country (2021-2026)
- 7.2.2 Global Physician Advisory Services Sales Value by Country (2027-2032)
- 7.3 USA
- 7.3.1 USA Physician Advisory Services Sales Value Growth Rate (2021-2032)
- 7.3.2 USA Physician Advisory Services Sales Value Share by Type, 2025 VS 2032
- 7.3.3 USA Physician Advisory Services Sales Value Share by Application, 2025 VS 2032
- 7.4 Canada
- 7.4.1 Canada Physician Advisory Services Sales Value Growth Rate (2021-2032)
- 7.4.2 Canada Physician Advisory Services Sales Value Share by Type, 2025 VS 2032
- 7.4.3 Canada Physician Advisory Services Sales Value Share by Application, 2025 VS 2032
- 7.5 Mexico
- 7.5.1 Mexico Physician Advisory Services Sales Value Growth Rate (2021-2032)
- 7.5.2 Mexico Physician Advisory Services Sales Value Share by Type, 2025 VS 2032
- 7.5.3 Mexico Physician Advisory Services Sales Value Share by Application, 2025 VS 2032
- 7.6 Germany
- 7.6.1 Germany Physician Advisory Services Sales Value Growth Rate (2021-2032)
- 7.6.2 Germany Physician Advisory Services Sales Value Share by Type, 2025 VS 2032
- 7.6.3 Germany Physician Advisory Services Sales Value Share by Application, 2025 VS 2032
- 7.7 France
- 7.7.1 France Physician Advisory Services Sales Value Growth Rate (2021-2032)
- 7.7.2 France Physician Advisory Services Sales Value Share by Type, 2025 VS 2032
- 7.7.3 France Physician Advisory Services Sales Value Share by Application, 2025 VS 2032
- 7.8 U.K.
- 7.8.1 U.K. Physician Advisory Services Sales Value Growth Rate (2021-2032)
- 7.8.2 U.K. Physician Advisory Services Sales Value Share by Type, 2025 VS 2032
- 7.8.3 U.K. Physician Advisory Services Sales Value Share by Application, 2025 VS 2032
- 7.9 Italy
- 7.9.1 Italy Physician Advisory Services Sales Value Growth Rate (2021-2032)
- 7.9.2 Italy Physician Advisory Services Sales Value Share by Type, 2025 VS 2032
- 7.9.3 Italy Physician Advisory Services Sales Value Share by Application, 2025 VS 2032
- 7.10 Spain
- 7.10.1 Spain Physician Advisory Services Sales Value Growth Rate (2021-2032)
- 7.10.2 Spain Physician Advisory Services Sales Value Share by Type, 2025 VS 2032
- 7.10.3 Spain Physician Advisory Services Sales Value Share by Application, 2025 VS 2032
- 7.11 Russia
- 7.11.1 Russia Physician Advisory Services Sales Value Growth Rate (2021-2032)
- 7.11.2 Russia Physician Advisory Services Sales Value Share by Type, 2025 VS 2032
- 7.11.3 Russia Physician Advisory Services Sales Value Share by Application, 2025 VS 2032
- 7.12 Netherlands
- 7.12.1 Netherlands Physician Advisory Services Sales Value Growth Rate (2021-2032)
- 7.12.2 Netherlands Physician Advisory Services Sales Value Share by Type, 2025 VS 2032
- 7.12.3 Netherlands Physician Advisory Services Sales Value Share by Application, 2025 VS 2032
- 7.13 Nordic Countries
- 7.13.1 Nordic Countries Physician Advisory Services Sales Value Growth Rate (2021-2032)
- 7.13.2 Nordic Countries Physician Advisory Services Sales Value Share by Type, 2025 VS 2032
- 7.13.3 Nordic Countries Physician Advisory Services Sales Value Share by Application, 2025 VS 2032
- 7.14 China
- 7.14.1 China Physician Advisory Services Sales Value Growth Rate (2021-2032)
- 7.14.2 China Physician Advisory Services Sales Value Share by Type, 2025 VS 2032
- 7.14.3 China Physician Advisory Services Sales Value Share by Application, 2025 VS 2032
- 7.15 Japan
- 7.15.1 Japan Physician Advisory Services Sales Value Growth Rate (2021-2032)
- 7.15.2 Japan Physician Advisory Services Sales Value Share by Type, 2025 VS 2032
- 7.15.3 Japan Physician Advisory Services Sales Value Share by Application, 2025 VS 2032
- 7.16 South Korea
- 7.16.1 South Korea Physician Advisory Services Sales Value Growth Rate (2021-2032)
- 7.16.2 South Korea Physician Advisory Services Sales Value Share by Type, 2025 VS 2032
- 7.16.3 South Korea Physician Advisory Services Sales Value Share by Application, 2025 VS 2032
- 7.17 India
- 7.17.1 India Physician Advisory Services Sales Value Growth Rate (2021-2032)
- 7.17.2 India Physician Advisory Services Sales Value Share by Type, 2025 VS 2032
- 7.17.3 India Physician Advisory Services Sales Value Share by Application, 2025 VS 2032
- 7.18 Australia
- 7.18.1 Australia Physician Advisory Services Sales Value Growth Rate (2021-2032)
- 7.18.2 Australia Physician Advisory Services Sales Value Share by Type, 2025 VS 2032
- 7.18.3 Australia Physician Advisory Services Sales Value Share by Application, 2025 VS 2032
- 7.19 Southeast Asia
- 7.19.1 Southeast Asia Physician Advisory Services Sales Value Growth Rate (2021-2032)
- 7.19.2 Southeast Asia Physician Advisory Services Sales Value Share by Type, 2025 VS 2032
- 7.19.3 Southeast Asia Physician Advisory Services Sales Value Share by Application, 2025 VS 2032
- 7.20 Brazil
- 7.20.1 Brazil Physician Advisory Services Sales Value Growth Rate (2021-2032)
- 7.20.2 Brazil Physician Advisory Services Sales Value Share by Type, 2025 VS 2032
- 7.20.3 Brazil Physician Advisory Services Sales Value Share by Application, 2025 VS 2032
- 7.21 Argentina
- 7.21.1 Argentina Physician Advisory Services Sales Value Growth Rate (2021-2032)
- 7.21.2 Argentina Physician Advisory Services Sales Value Share by Type, 2025 VS 2032
- 7.21.3 Argentina Physician Advisory Services Sales Value Share by Application, 2025 VS 2032
- 7.22 Chile
- 7.22.1 Chile Physician Advisory Services Sales Value Growth Rate (2021-2032)
- 7.22.2 Chile Physician Advisory Services Sales Value Share by Type, 2025 VS 2032
- 7.22.3 Chile Physician Advisory Services Sales Value Share by Application, 2025 VS 2032
- 7.23 Colombia
- 7.23.1 Colombia Physician Advisory Services Sales Value Growth Rate (2021-2032)
- 7.23.2 Colombia Physician Advisory Services Sales Value Share by Type, 2025 VS 2032
- 7.23.3 Colombia Physician Advisory Services Sales Value Share by Application, 2025 VS 2032
- 7.24 Peru
- 7.24.1 Peru Physician Advisory Services Sales Value Growth Rate (2021-2032)
- 7.24.2 Peru Physician Advisory Services Sales Value Share by Type, 2025 VS 2032
- 7.24.3 Peru Physician Advisory Services Sales Value Share by Application, 2025 VS 2032
- 7.25 Saudi Arabia
- 7.25.1 Saudi Arabia Physician Advisory Services Sales Value Growth Rate (2021-2032)
- 7.25.2 Saudi Arabia Physician Advisory Services Sales Value Share by Type, 2025 VS 2032
- 7.25.3 Saudi Arabia Physician Advisory Services Sales Value Share by Application, 2025 VS 2032
- 7.26 Israel
- 7.26.1 Israel Physician Advisory Services Sales Value Growth Rate (2021-2032)
- 7.26.2 Israel Physician Advisory Services Sales Value Share by Type, 2025 VS 2032
- 7.26.3 Israel Physician Advisory Services Sales Value Share by Application, 2025 VS 2032
- 7.27 UAE
- 7.27.1 UAE Physician Advisory Services Sales Value Growth Rate (2021-2032)
- 7.27.2 UAE Physician Advisory Services Sales Value Share by Type, 2025 VS 2032
- 7.27.3 UAE Physician Advisory Services Sales Value Share by Application, 2025 VS 2032
- 7.28 Turkey
- 7.28.1 Turkey Physician Advisory Services Sales Value Growth Rate (2021-2032)
- 7.28.2 Turkey Physician Advisory Services Sales Value Share by Type, 2025 VS 2032
- 7.28.3 Turkey Physician Advisory Services Sales Value Share by Application, 2025 VS 2032
- 7.29 Iran
- 7.29.1 Iran Physician Advisory Services Sales Value Growth Rate (2021-2032)
- 7.29.2 Iran Physician Advisory Services Sales Value Share by Type, 2025 VS 2032
- 7.29.3 Iran Physician Advisory Services Sales Value Share by Application, 2025 VS 2032
- 7.30 Egypt
- 7.30.1 Egypt Physician Advisory Services Sales Value Growth Rate (2021-2032)
- 7.30.2 Egypt Physician Advisory Services Sales Value Share by Type, 2025 VS 2032
- 7.30.3 Egypt Physician Advisory Services Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
- 8.1 R1 RCM
- 8.1.1 R1 RCM Company Information
- 8.1.2 R1 RCM Business Overview
- 8.1.3 R1 RCM Physician Advisory Services Revenue and Gross Margin (2021-2026)
- 8.1.4 R1 RCM Physician Advisory Services Product Portfolio
- 8.1.5 R1 RCM Recent Developments
- 8.2 Remedi Health Solutions
- 8.2.1 Remedi Health Solutions Company Information
- 8.2.2 Remedi Health Solutions Business Overview
- 8.2.3 Remedi Health Solutions Physician Advisory Services Revenue and Gross Margin (2021-2026)
- 8.2.4 Remedi Health Solutions Physician Advisory Services Product Portfolio
- 8.2.5 Remedi Health Solutions Recent Developments
- 8.3 Physician Advisory Solutions
- 8.3.1 Physician Advisory Solutions Company Information
- 8.3.2 Physician Advisory Solutions Business Overview
- 8.3.3 Physician Advisory Solutions Physician Advisory Services Revenue and Gross Margin (2021-2026)
- 8.3.4 Physician Advisory Solutions Physician Advisory Services Product Portfolio
- 8.3.5 Physician Advisory Solutions Recent Developments
- 8.4 MedsRole
- 8.4.1 MedsRole Company Information
- 8.4.2 MedsRole Business Overview
- 8.4.3 MedsRole Physician Advisory Services Revenue and Gross Margin (2021-2026)
- 8.4.4 MedsRole Physician Advisory Services Product Portfolio
- 8.4.5 MedsRole Recent Developments
- 8.5 Sound Physician
- 8.5.1 Sound Physician Company Information
- 8.5.2 Sound Physician Business Overview
- 8.5.3 Sound Physician Physician Advisory Services Revenue and Gross Margin (2021-2026)
- 8.5.4 Sound Physician Physician Advisory Services Product Portfolio
- 8.5.5 Sound Physician Recent Developments
- 8.6 Xsolis
- 8.6.1 Xsolis Company Information
- 8.6.2 Xsolis Business Overview
- 8.6.3 Xsolis Physician Advisory Services Revenue and Gross Margin (2021-2026)
- 8.6.4 Xsolis Physician Advisory Services Product Portfolio
- 8.6.5 Xsolis Recent Developments
- 8.7 AppriseMD
- 8.7.1 AppriseMD Company Information
- 8.7.2 AppriseMD Business Overview
- 8.7.3 AppriseMD Physician Advisory Services Revenue and Gross Margin (2021-2026)
- 8.7.4 AppriseMD Physician Advisory Services Product Portfolio
- 8.7.5 AppriseMD Recent Developments
- 8.8 DCCS Consulting
- 8.8.1 DCCS Consulting Company Information
- 8.8.2 DCCS Consulting Business Overview
- 8.8.3 DCCS Consulting Physician Advisory Services Revenue and Gross Margin (2021-2026)
- 8.8.4 DCCS Consulting Physician Advisory Services Product Portfolio
- 8.8.5 DCCS Consulting Recent Developments
- 8.9 CorroHealth, Inc
- 8.9.1 CorroHealth, Inc Company Information
- 8.9.2 CorroHealth, Inc Business Overview
- 8.9.3 CorroHealth, Inc Physician Advisory Services Revenue and Gross Margin (2021-2026)
- 8.9.4 CorroHealth, Inc Physician Advisory Services Product Portfolio
- 8.9.5 CorroHealth, Inc Recent Developments
- 8.10 Precision Healthcare Consultant
- 8.10.1 Precision Healthcare Consultant Company Information
- 8.10.2 Precision Healthcare Consultant Business Overview
- 8.10.3 Precision Healthcare Consultant Physician Advisory Services Revenue and Gross Margin (2021-2026)
- 8.10.4 Precision Healthcare Consultant Physician Advisory Services Product Portfolio
- 8.10.5 Precision Healthcare Consultant Recent Developments
- 8.11 Med-Metrix
- 8.11.1 Med-Metrix Company Information
- 8.11.2 Med-Metrix Business Overview
- 8.11.3 Med-Metrix Physician Advisory Services Revenue and Gross Margin (2021-2026)
- 8.11.4 Med-Metrix Physician Advisory Services Product Portfolio
- 8.11.5 Med-Metrix Recent Developments
- 8.12 EdiPhy Advisors
- 8.12.1 EdiPhy Advisors Company Information
- 8.12.2 EdiPhy Advisors Business Overview
- 8.12.3 EdiPhy Advisors Physician Advisory Services Revenue and Gross Margin (2021-2026)
- 8.12.4 EdiPhy Advisors Physician Advisory Services Product Portfolio
- 8.12.5 EdiPhy Advisors Recent Developments
- 8.13 Optum
- 8.13.1 Optum Company Information
- 8.13.2 Optum Business Overview
- 8.13.3 Optum Physician Advisory Services Revenue and Gross Margin (2021-2026)
- 8.13.4 Optum Physician Advisory Services Product Portfolio
- 8.13.5 Optum Recent Developments
9 Concluding Insights
10 Appendix
- 10.1 Reasons for Doing This Study
- 10.2 Research Methodology
- 10.3 Research Process
- 10.4 Authors List of This Report
- 10.5 Data Source
- 10.5.1 Secondary Sources
- 10.5.2 Primary Sources
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
$4,250USD
Buy nowPDF by email within 3–5 working days after payment confirmation.
Talk to an analyst